1# FIRMWARE LICENSE TERMS 2# 3# 4# Copyright (c) Marvell International Ltd. 5# 6# All rights reserved. 7# 8# Redistribution. Redistribution and use in binary form, without 9# modification, are permitted provided that the following conditions are 10# met: 11# 12# * Redistributions must reproduce the above copyright notice and the 13# following disclaimer in the documentation and/or other materials 14# provided with the distribution. 15# 16# * Neither the name of Marvell International Ltd. nor the names of its 17# suppliers may be used to endorse or promote products derived from this 18# software without specific prior written permission. 19# 20# * No reverse engineering, decompilation, or disassembly of this software 21# is permitted. 22# 23# Limited patent license. Marvell International Ltd. grants a world-wide, 24# royalty-free, non-exclusive license under patents it now or hereafter 25# owns or controls to make, have made, use, import, offer to sell and sell 26# ("Utilize") this software, but solely to the extent that any such patent 27# is necessary to Utilize the software alone, or in combination with an 28# operating system licensed under an approved Open Source license as 29# listed by the Open Source Initiative at http://opensource.org/licenses. 30# The patent license shall not apply to any other combinations which 31# include this software. No hardware per se is licensed hereunder. 32# 33# DISCLAIMER. THIS SOFTWARE IS PROVIDED BY THE COPYRIGHT HOLDERS AND 34# CONTRIBUTORS "AS IS" AND ANY EXPRESS OR IMPLIED WARRANTIES, INCLUDING, 35# BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY AND 36# FITNESS FOR A PARTICULAR PURPOSE ARE DISCLAIMED. IN NO EVENT SHALL THE 37# COPYRIGHT OWNER OR CONTRIBUTORS BE LIABLE FOR ANY DIRECT, INDIRECT, 38# INCIDENTAL, SPECIAL, EXEMPLARY, OR CONSEQUENTIAL DAMAGES (INCLUDING, BUT 39# NOT LIMITED TO, PROCUREMENT OF SUBSTITUTE GOODS OR SERVICES; LOSS OF 40# USE, DATA, OR PROFITS; OR BUSINESS INTERRUPTION) HOWEVER CAUSED AND ON 41# ANY THEORY OF LIABILITY, WHETHER IN CONTRACT, STRICT LIPOSSIBILITY OF SUCH DAMAGE. 42# 43# 44begin 644 mwlboot.fw 45M`P``Z@4```````````````````!0`)_E$`\![@``X.-($)_E#`"!Y1@`D>4@ 46M"*#A"P!0XP0```H;`%#C`@``"BP`G^4P`('E`0``ZB0`G^4P`('E(-"?Y2`` 47MG^4`$)#E'""?Y0`0@N4&``#J=!\````@`(`2"0``YSH'%``@``0$````_/\` 48M`,2`C^(#`)CH"`"`X`@0@>`!L$#B`0!0X1,```IP`+#H!0!4X?K__PH!`!3C 49M"T"$$`$`%>,+4(40`@`5XPE0A1`#4,7C$&!6XHP0M"B,$*4H^___BH9NL.$, 50M`+0H#`"E*`1PE$0$<(5$Z?__Z@@@F.4,,)CE""""X`@P@^`!P$+B`'"@XP`` 51MH.,`8*#C`+"@XP,`4N$0```+,`"RZ`$`%.,,0(00`@`4XPE`A!`#0,3C$%!5 52MXL$(I"C\__^*A5ZPX4$`I"@$<(1$\/__ZA@````\````/````%0````$\!_E 53M@`$`P````````````````*@!``````#`L`8``%@(````"`#`D````*@!```` 54M````L`8`P`````"0"`#`<````'!'<$<`1PA'$$<81R!'*$<P1SA'>$<```,` 55M4N.#``":`\`0X@@```H!,-'D`@!<XPP@@N`!P-&4`3#`Y`$PT30$($+B`<#` 56ME`$PP#0#,!'B8P``"@0@4N)T```Z`\`QYP(`4^,(```*#P``BBPTH.$$P+'E 57M!"!2X@P\@^$$,(#D^?__*@$0@>)H``#J+#B@X03`L>4$(%+B##B#X00P@.3Y 58M__\J`A"!XF```.HL/*#A!,"QY00@4N(,-(/A!#"`Y/G__RH#$('B6```ZGA' 59M```>_R_A>$<```Y0H.$\``#K!>"@X0!`H.$-$*#A"C"@X0<`P.-@T(#B$$`M 60MZ?H``.L00+WH!]#!XP!@H.,`<*#C`("@XP"PH.,$P*#AP`FLZ,`)K.C`":SH 61MP`FLZ!]`+>D``*#C`!"@X____^M`$('B`6"`X$1OAN(<8(3E&!"$Y0$`H.,4 62M`(3E'T"]Z`(0H.$>_R_A>$<``!!`+>D`(*#A``"@X____^L00+WH'O\OX=3_ 63M_^LV``#Z',"?Y0_`C.`!`!SC#>"/$@_@H`$<_R_A`<"/XAS_+^$`\%+X[0,` 64M`'A'```!0"WI4```^P%`O>@!``#J>$<`````X.-3``#J>$<`````G^4>_R_A 65MH`@`P'A'```00"WI("!2X@4``#H84+$H&%"@*!A0L2@84*`H("!2(OG__RH" 66MSK#A&%"Q*!A0H"@8`+%(&`"@2!!`O>@"S[#A!#"1)`0P@"0>_R\!@B^PX0$@ 67MT40!,-$D`<#1)`$@P$0!,,`D`<#`)![_+^$0M00<`/``^"`<__>L[Q"\"+P8 68M1_"U!!P-'(.P`/`4Z@"4`94`(`#P`/@"D"9(:49X1`#P`/@%'`X<`*D#R0#P 69M`/@`\`#X`/``^``A`"``\`#X!QS_]Y;O!!P`(0=B`"``\`#X01QA8@`A`"`` 70M\`#X`"&@8@`@`/``^``AX&(`(`#P`/@@8P#P`/@`\`#X`/``^`#P`/@`\`#X 71M`/``^`#P`/@`\`#X*!PQ'`.P\+P(O!A'"+4`\`#X`/``^`#P`/@!L`B\&$<` 72M`)0```!X1P``&`"@XP@0G^56-!+O'O\OX0D````F``(`>$<``![_+^%X1P`` 73M$$`MZ:'__^L$`(#B$$"]Z![_+^$`1P``_K4`(`*0`9!-2`$FP&L&*!G2`J,; 74M7%L`GT0```,$!`0$!``F1TH`(1%@A`!&2%%@D6!&30%9*!S_]S?^1$@`6?_W 75M,OX`X/[G`9@`*`G004B`:0`,``(0(0A#!1P`(`&0`.`0)3Q/*!PY6?_W'OX` 76M+@30.D@`6?_W%_X`)@`@`)`W2`!9__<0_C!(+D\/R`_'$#\X:`$H#]`$*`W0 77M`2`N3P5#*!PY6?_W`/XL2`!9__?[_0"8`"CCT")(`&@!*!C0!"@,T21/`"`Y 78M6?_W[OTC2`!9__?I_1M(0&C_]X__&4D`(`A@2&"(8,A@`I@`**O0_KT93Q-( 79M.5F%:"@<__?5_19(`%G_]]#]`"``D!1(`%G_]\K]$T@`6?_WQOT`*`'1`2;< 80MYP$@!4,H'#E9__>]_0I(`%G_][C]`)@`*,_1Y>?`_P``D`@`P!@(`,``"@#` 81M``@`P``@`(!X"`#`2`@`P#`(`,!@"`#`"$L:8!AA&6(#(,`"!"H!T&<@@`$# 82M24`Q"&`8:``H_-$(8'!'`.@`@`0`G^5`'8#B#O"@X0`0``0!204@2&%P1P`, 83M`(!P1P```"!P1W!'``!P1P``<$<```-(!$D(@$`'08A!@'!'```$@```(``` 84M@`$AR0=(B$`'_-5P1P))`T@!@(\AP8-P1P2````@``"``2')!XAB<$<!(<D' 85MB&-P1P5*@+42'07*`DD$.O_W4NT`(("]``H`P)`(`,"`M?_WZ_X`(("]```$ 86M(4@'06,`(4%B<$<!(<D'2&I`!_S5<$<!(<@'`6($(4%C<$<!(<D'B(%P1P$A 87MR0?(8W!'<$<```=(`+4`:$((!4E2`$`YR&F`!_S5"&D#2?_W<O\`O0``0`P` 88M@``*`,!P1P``!$D(8`-(!2%`.$%A`"'!87!'``!`#`"`<$<```)(`"$!@0TA 89M`8!P1R`!`(`"20B)P`?\U7!'```@`0"``T@-(0&``"&!@0$A@8!P1R`!`(`! 90M20AA<$<````!`(`!24AA<$<````!`(`!200@"(-P1T```(`#20B)0`?\U0`@ 91M"(%P1P``0```@`%)!"`(@W!'0```@`$AR0>(8G!'`2')!TAA<$=X1P``$$`M 92MZ2C__^L`$*#C`!"`Y1!`O>@>_R_A004`P!$%`,`M!@#`>08`P*4%`,#M!0#` 93M704`P!D%`,!-!@#`C08`P+D%`,`)!@#`-04`P`D%`,`=!@#`908`P)D%`,#% 94M!0#`'04`P/T$`,`-!@#`608`P(T%`,#!!0#`904`P`T%`,!E!0#`904`P&4% 95>`,!E!0#`504`P!4%`,!!!@#`A08`P+$%`,#Q!0#` 96` 97end 98